Clinical Trials Browser

Phase 2 × INDUSTRY × S 1 (combination) × Clear all

NCT06256328 2026-03-13

A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)

Phase 2 Active not recruiting

Gastrointestinal

Stomach Neoplasms

NCT04566380 2025-06-03

ONO-4538 Phase II Rollover Study (ONO-4538-98)

Phase 2 Recruiting

Pan-tumor

NCT00651742 2024-09-19

Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer

Phase 2 Completed

28 enrolled 16 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02855125 2024-09-19

A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1

Phase 2 Completed

128 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT00652054 2024-09-03

Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00652561 2024-09-03

Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

Advanced Non-Small Cell Lung Cancer

NCT01388790 2013-11-20

Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer

Phase 2 Completed

40 enrolled 7 charts

Gastrointestinal

Stomach Neoplasms

NCT00816543 2012-12-18

Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

NCT00569335 2012-11-02

Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms

NCT00569790 2012-11-02

Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT00891332 2012-01-18

Study of S-1 Plus LV for Untreated Metastatic Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms